Study of Immunotherapy to Treat Advanced Prostate Cancer
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if advanced prostate cancer patients that are
treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT alone